Skip to main content
AmigoFish

Docs Who Lift

Docs Who LiftAudio

Format:
Podcast
New episodes:
Every two weeks
Typical length:
about 40 minutes
Latest episode:
Not rated yet

About this show

Drs. Spencer and Karl Nadolsky talk about nutrition, medicine, and fitness through the lens of two physicians who lift weights. Both doctors are former NCAA division 1 wrestlers who have gone into medicine. Dr. Spencer Nadolsky is a board certified family physician specialized in obesity medicine and lipidology. Dr. Karl Nadolsky is a board certified endocrinologist also specialized in obesity medicine.

Covers: nutrition, medicine, obesity medicine, fitness, glp-1 medications, weight loss drugs, peptides, menopause, endocrinology, bone health

Show details and episodes come from the publisher's public feed at feeds.simplecast.com. Last updated . Names, artwork and text belong to their publishers.

Recently on this show

Summary of recent episodes, drawn from the publisher's feed.

Docs Who Lift is a podcast where two physicians who lift weights discuss nutrition, medicine, and fitness. Recent episodes cover peptides like BPC-157, menopause misinformation, next-generation GLP-1 drugs, food noise, and renaming PCOS.

Report a problem with this summary

Cosmos

Similar in subject

See the full Cosmos

Similar shows

See all Health shows

Explore more

Episodes

  • GLP-1 meds and macular degeneration

    · 33 min

    Learn what age-related macular degeneration (AMD) is What causes AMD The types of AMD The update on NAION - listen to last year's podcast all about it Why we aren't too concerned Click here to join Dr. Spencer's online clinic Vineyard Click to read the JAMA AMD article (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2834964) Click to read the Ophthalmology journal AMD article (https://pubmed.ncbi.nlm.nih.gov/39863057/) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

    Not rated yet
  • Menopause, MHT, and GLP-1 medicines

    · 27 min

    - Menopausal hormonal therapy should not be a blanket recommendation for everyone going through menopause - Weight management in women is influenced by hormonal changes throughout life stages. - Retrospective analyses can provide insights but have limitations. - The wellness industry often oversimplifies complex medical issues. - Hormonal replacement therapy may have subtle benefits for weight management. - Confounding factors like SSRIs can complicate weight loss efforts. - A holistic approach is essential for managing women's health during menopause. - Education and awareness are crucial for women navigating menopause. - Future research should focus on randomized controlled trials for better clarity. - Understanding individual patient experiences is key to effective treatment. Click here to see her study (https://pubmed.ncbi.nlm.nih.gov/40074721/) Click here to follow Dr. Tchang on X (https://x.com/BevTchangMD) Click here to join Dr. Spencer's clinic Vineyard (https://joinvineyard.com/) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

    Not rated yet
  • The Science of Myostatin inhibitors, GLP-1 meds and Muscle Mass

    · 28 min

    - Dr. Grant Tinsley joins the discussion as the body composition expert. - Myostatin is a key regulator of muscle growth. - Wendy Whippete the most jacked muscled up dog (https://www.timescolonist.com/local-news/wendy-the-whippet-famed-for-massive-muscles-has-died-4645620) - The concern of GLP-1 receptor agonists and muscle mass loss. - Overview of Courage trial looking at semaglutide and trevogrumab and lean mass loss (https://newsroom.regeneron.com/news-releases/news-release-details/interim-results-ongoing-phase-2-courage-trial-confirm-potential) - Upcoming Believe trial coming out (bimagrumab and semaglutide) (https://www.adameetingnews.org/researchers-to-share-weight-loss-results-from-bimagrumab-and-semaglutide-combo/) - Exercise remains crucial for muscle health and function. - MRI data from SURPASS MRI provides new insights into muscle volume changes. (https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00027-0/fulltext) - The combination of medications may have varying effects on muscle mass. - Caution is advised regarding the long-term effects of new drugs. - Clinical benefits of medications often outweigh concerns about muscle loss. - Future research will explore the synergy between exercise and medication. Other docs who lift podcasts with Dr. Grant: Tirzepatide muscle loss (https://podcasts.apple.com/us/podcast/tirzepatide-and-muscle-loss-with-dr-grant-tinsley/id1611961208?i=1000696844484) Lean mass loss and GLP-1 meds (https://podcasts.apple.com/us/podcast/glp-1-agonists-and-lean-body-mass-loss-part-2-w-dr/id1611961208?i=1000610443673) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

    Not rated yet
  • Current State of Nutrition Research and MAHA

    · 56 min

    Takeaways: - The MAHA report aims to address public health issues but lacks actionable policies. - Historical context is crucial for understanding current dietary guidelines. - Funding for nutrition research has been inadequate, impacting the quality of data. - Public perception of nutrition often outpaces scientific evidence. - The evolution of dietary guidelines reflects political and social influences. - There is a need for more rigorous nutrition science to inform policy. - The dietary guidelines have not significantly improved population health metrics. - Political will is essential for implementing effective nutrition policies. - Nutrition science faces challenges in funding and research infrastructure. - The MAHA report's recommendations may be more performative than substantive. Food policy changes are often superficial and ineffective. - There is a significant disconnect between policy and actual health outcomes. - Nutrition science is underfunded and lacks high-quality research. - Misinformation in nutrition can lead to harmful public health outcomes. - The focus on food additives distracts from more pressing issues like obesity. - Experts are being sidelined in favor of political agendas. - Public trust in health recommendations has eroded post-COVID. - Nutrition policies need to be based on solid scientific evidence. - The food industry needs clearer guidance on reformulating products. - Future nutrition policies must prioritize public health over political gain Read Dr. Kevin's paper (https://pubmed.ncbi.nlm.nih.gov/40367956/) Follow Dr. Kevin on instagram (https://www.instagram.com/kcklatt/?hl=en) Join Dr. Spencer's clinic (https://joinvineyard.com/) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

    Not rated yet
  • Joy Prescriptions

    · 46 min

    Click to read Joy Prescriptions (https://www.amazon.com/Joy-Prescriptions-Learned-Perfection-Connection/dp/0306834537) Drs. Karl and Spencer talk to Dr. Tiffany Moon all about Joy Prescriptions. Learn how to stop chasing perfection and embrace connection. 00:00Introduction to Dr. Tiffany Moon 02:02Journey to Reality TV: The Real Housewives of Dallas 05:58Life After Reality TV: Finding Joy and Purpose 09:59The Joy Prescription: A New Approach to Life 17:01Work-Life Integration: Balancing Career and Family 22:09Empowering Women: The Lead Her Summit 22:33Tiffany's Journey: From Childhood to Medical Success 24:43The Quest for Joy: Breaking the Hedonic Treadmill 26:42Finding Gratitude and Connection in Life 28:37Coping Mechanisms: Humor and Self-Reflection 29:57The Joy Prescription: A Path for High Achievers 32:29Reconstructing Identity: Beyond External Validation 35:37The Impact of Sports on Identity and Achievement 40:54Closing Thoughts: Embracing Joy and Connection Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

    Not rated yet
  • Zepbound versus Wegovy

    · 20 min

    - Tirzepatide is more effective for weight loss than semaglutide. - Cost-effectiveness is crucial in prescribing weight loss medications. - Patients with severe obesity should receive more expensive medications for better outcomes. - Both medications show significant benefits for obesity-related conditions. - Long-term studies indicate sustained weight loss with both drugs. - Gender differences affect weight loss outcomes with these medications. - Safety profiles show tirzepatide may be better tolerated than semaglutide. - The need for affordable drug pricing is emphasized. - Clinical benefits extend beyond weight loss to include metabolic health. - Future studies are needed to confirm cardiovascular benefits of tirzepatide. Click here to see the study (https://www.nejm.org/doi/full/10.1056/NEJMoa2416394) Click here to join Dr. Spencer's new online clinic (https://joinvineyard.com/) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

    Not rated yet
  • Semaglutide for metabolic dysfunction associated steatotic liver disease (MASH).

    · 22 min

    Takeaways - MASH is a significant obesity-related complication. - Semaglutide shows promise in treating MASH. - Weight loss is crucial for improving liver health. - Bariatric surgery remains the most effective treatment. - The Essence trial indicates a 63% resolution of NASH. - New medications are being developed for obesity treatment. - Early intervention is key to preventing severe liver damage. - Accessibility of medications is a major concern. - Comparative studies are essential for evaluating new treatments. - Future treatments may include innovative delivery methods. Chapters 00:00 Introduction to MASH and Semaglutide Study 04:29 Understanding Metabolic Dysfunction and Its Implications 08:02 Essence Trial: Semaglutide's Impact on MASH 12:58 Comparative Analysis of New Treatments for MASH 17:30 The Future of Obesity Treatment and Drug Accessibility Join Vineyard - Dr. Spencer's online clinic (https://joinvineyard.com/) See the study (https://www.nejm.org/doi/full/10.1056/NEJMoa2413258) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

    Not rated yet
  • Top 5 Women's Fitness Myths

    · 36 min

    Drs. Karl and Spencer chat with return guest Dr. Lauren Semple about creatine, protein, cortisol, fasting exercise, and training in women. Follow Dr. Lauren's instagram (https://www.instagram.com/drlaurencs1/) Join Dr. Spencer's online clinic (https://joinvineyard.com/) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

    Not rated yet
  • GLP-1 and metabolism and depression

    · 25 min

    Drs. Karl and Spencer discuss a new study looking at tirzepatide and metabolic rate. They also discuss a patient case of tirzepatide induced anhedonia. Here is the tirzepatide study (https://www.cell.com/cell-metabolism/abstract/S1550-4131(25)00114-7) If interested in joining Dr. Spencer's clinic Vineyard - Click Here (https://joinvineyard.com/join/) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

    Not rated yet
  • Do GLP-1 meds cause more fat cells?

    · 25 min

    Drs. Karl and Spencer discuss the claim that GLP-1 meds cause more fat cells. Learn about if and how GLP-1 meds increase fat cells and what that means along with other claims about these medicine. Join Dr. Spencer's online clinic that specializes in GLP-1 medicines (https://joinvineyard.com/join/) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

    Not rated yet